Risk factors and primary prevention of cardiovascular disease
Brohet, C.
Journal de Pharmacie de Belgique 50(1): 20-24
1995
ISSN/ISBN: 0047-2166 PMID: 7602446 Document Number: 450542
Document emailed within 1 workday
Related Documents
Lowe, G.; Rumley, A.; Norrie, J.; Ford, I.; Shepherd, J.; Cobbe, S.; Macfarlane, P.; Packard, C. 2000: Blood rheology, cardiovascular risk factors, and cardiovascular disease: the West of Scotland Coronary Prevention Study Thrombosis and Haemostasis 84(4): 553-558Henriquez, D.; Dikow, R.; Ritz, E. 2004: Cardiovascular disease in chronic renal failure. Risk factors and prevention Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 24 Suppl. 4: 34-39
Bellomo, A.; Mancinella, M.; Troisi, G.; Marigliano, V. 2009: Relationship between atrial fibrillation and other cardiovascular risk factors in Alzheimer's disease. New prevention opportunities Recenti Progressi in Medicina 100(3): 124-126
Osler, M.; Jespersen, N.B.; Lous, J.; Rasmussen, N.K. 1992: Cardiovascular risk factors--extent and self-assessed risk in relation to prevention of cardiovascular diseases. A questionnaire among 3,956 men and women aged 24-65 years in Vejle County, Slangerup and Helsinge municipalities Ugeskrift for Laeger 154(9): 538-543
Stamler, J. 1973: Heart disease prevention in industry. Primary prevention in mass community efforts to control the major coronary risk factors: the challenges and possibilities--critical issues and outlook for the future Journal of Occupational Medicine.: Official Publication of the Industrial Medical Association 15(1): 54-59
Wilhelmsen, L. 1977: Primary and secondary risk factors for coronary heart disease: their role in prevention Medical Journal of Malaysia 31(4): 296-301
Selak, V.; Jackson, R.; Poppe, K.; Kerr, A.; Wells, S. 2018: Are the benefits of aspirin likely to exceed the risk of major bleeds among people in whom aspirin is recommended for the primary prevention of cardiovascular disease? New Zealand Medical Journal 131(1484): 19-25
Aghaeishahsavari, M.; Noroozianavval, M.; Veisi, P.; Parizad, R.; Samadikhah, J. 2006: Cardiovascular disease risk factors in patients with confirmed cardiovascular disease Saudi Medical Journal 27(9): 1358-1361
Bongard, V.; Ferrières, J. 2006: Cardiovascular risk factors and prevention La Revue du Praticien 56(1): 79-87 94
Meister, W. 1989: Risk factors and prevention of cardiovascular diseases Der Internist 30(5): 276-282
Béliard-Lasserre, S. 2016: Should we prescribe statins for primary prevention of cardiovascular risk? Rather yes La Revue du Praticien 66(3): 332-334
Volpe, M.; Tocci, G. 2012: Global cardiovascular risk management in primary prevention Current Vascular Pharmacology 10(6): 709-711
Lobo, R.A. 1988: Lipids, clotting factors, and diabetes: endogenous risk factors for cardiovascular disease American Journal of Obstetrics and Gynecology 158(6 Part 2): 1584-1591
Richard, J.L.; Delahaye, F. 1998: Cardiovascular prevention, primary or secondary, in high risk patients Archives des Maladies du Coeur et des Vaisseaux 91(12): 1495-1502
Garrett, R.E. 1986: Primary prevention of cardiovascular disease Journal of Family Practice 22(3): 222 224
Benet Martí, J.M.; Cortés Vargas, P.; Solé Villa, J.; Guarga Rojas, A.; Marquet Palomer, R.; Muñoz Grimaldo, M.; Pascual Talavera, J.M. 1990: Cardiovascular risk factors. An audit of their detection in primary care Atencion Primaria 7(Special Issue): 20
Danchin, N. 2005: Cardiovascular risk factors: on which elements to base the actions of prevention? La Revue du Praticien 55(16): 1753-1754
Marques-Vidal, P.; Bongard, V.; Arveiler, D.; Amouyel, P.; Ducimetière, P.; Ferrières, J. 2002: Medical cost of cardiovascular risk factors prevention in France Archives des Maladies du Coeur et des Vaisseaux 95(4): 275-281
Nanchen, D.; Chiolero, A.; Marques-Vidal, P-Manuel.; Cornuz, J.; Waeber, Gérard.; Vollenweider, P.; Rodondi, N. 2010: Statin prescription in primary prevention: which cardiovascular risk score should be used in Switzerland? Revue Medicale Suisse 6(239): 488-90 492-3
Miser, W.Fred. 2011: Appropriate aspirin use for primary prevention of cardiovascular disease American Family Physician 83(12): 1380-1386